AXDX - Accelerate Diagnostics, Inc.
| Previous Close | 19.15 |
| Open | 19.24 |
| Bid | 17.60 x 1300 |
| Ask | 19.85 x 1100 |
| Day's Range | 19.23 - 19.92 |
| 52 Week Range | 10.23 - 27.65 |
| Volume | 258,883 |
| Avg. Volume | 389,700 |
| Market Cap | 1.073B |
| Beta (3Y Monthly) | 4.08 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.50 |
| Earnings Date | Feb 19, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 17.00 |
- Zacks•4 days ago
Earnings Preview: Accelerate Diagnostics (AXDX) Q4 Earnings Expected to Decline
Accelerate Diagnostics (AXDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Markit•8 days ago
See what the IHS Markit Score report has to say about Accelerate Diagnostics Inc.
Accelerate Diagnostics Inc NASDAQ:AXDXView full report here! Summary * ETFs holding this stock have seen outflows over the last one-month * Bearish sentiment is high * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | NegativeShort interest is extremely high for AXDX with more than 20% of shares on loan. This means that investors who seek to profit from falling equity prices are currently targeting AXDX. Money flowETF/Index ownership | NegativeETF activity is negative. Over the last one-month, outflows of investor capital in ETFs holding AXDX totaled $3.17 billion. Additionally, the rate of outflows appears to be accelerating. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
- GlobeNewswire•8 days ago
Factors of Influence in 2019, Key Indicators and Opportunity within New Relic, Clean Harbors, Sage Therapeutics, Accelerate Diagnostics, Fortinet, and Colfax — New Research Emphasizes Economic Growth
NEW YORK, Feb. 08, 2019 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
- PR Newswire•11 days ago
Accelerate Diagnostics schedules call to review 2018 fourth quarter and full-year results
TUCSON, Ariz. , Feb. 5, 2019 /PRNewswire/ -- Accelerate Diagnostics, Inc. announced today that management will host a conference call on Tuesday, February 19, 2019 at 4:30 p.m. Eastern Time to review 2018 ...
- PR Newswire•last month
Accelerate Diagnostics to Present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco
TUCSON, Ariz., Jan. 2, 2019 /PRNewswire/ -- Accelerate Diagnostics announced today that the company is scheduled to present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 9, 2019, at 2:30 PM Pacific Time. About Accelerate Diagnostics, Inc. Accelerate Diagnostics, Inc. (AXDX), is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis.
- Simply Wall St.•2 months ago
Need To Know: Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Insiders Have Been Buying Shares
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. Unfortunately, there are also plenty of examples of share prices Read More...
- PR Newswire•3 months ago
Accelerate Diagnostics Pledges Matching Support for Sepsis Alliance #GivingTuesday Movement to Raise Awareness of Sepsis as a Medical Emergency
TUCSON, Ariz., Nov. 27, 2018 /PRNewswire/ -- Accelerate Diagnostics, Inc. has joined with Sepsis Alliance to celebrate #GivingTuesday, November 27th, a global day of giving that harnesses the collective power of individuals, communities and organizations to encourage philanthropy and to celebrate generosity worldwide. Accelerate Diagnostics has pledged to match the first $15,000 donated to Sepsis Alliance on #GivingTuesday to help raise awareness of sepsis as an often preventable medical emergency and improve outcomes for patients affected by sepsis through expanded healthcare provider education. Any infection can lead to sepsis, which is now the third leading cause of death in the United States.
- Thomson Reuters StreetEvents•3 months ago
Edited Transcript of AXDX earnings conference call or presentation 6-Nov-18 9:15pm GMT
Q3 2018 Accelerate Diagnostics Inc Earnings Call
- Zacks•3 months ago
Accelerate Diagnostics (AXDX) Reports Q3 Loss, Lags Revenue Estimates
Accelerate Diagnostics (AXDX) delivered earnings and revenue surprises of 6.82% and -53.05%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
- Associated Press•3 months ago
Accelerate Diagnostics: 3Q Earnings Snapshot
On a per-share basis, the Tucson, Arizona-based company said it had a loss of 41 cents. The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research ...
- PR Newswire•3 months ago
Accelerate Diagnostics reports Q3 2018 financial results
Revenue Placements up 40 Percent in U.S., Total Revenue up 64 Percent TUCSON, Ariz. , Nov. 6, 2018 /PRNewswire/ -- Accelerate Diagnostics, Inc. today announced financial results for the quarter ending ...
- Zacks•4 months ago
Earnings Preview: Accelerate Diagnostics (AXDX) Q3 Earnings Expected to Decline
Accelerate Diagnostics (AXDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- PR Newswire•4 months ago
Accelerate Diagnostics to Review Third Quarter 2018 Results on November 6th
TUCSON, Ariz. , Oct. 17, 2018 /PRNewswire/ -- Accelerate Diagnostics, Inc. announced today that it will host a conference call on Tuesday, November 6, 2018 to review the company's third quarter 2018 financial ...
- Zacks•4 months ago
Accelerate Diagnostics (AXDX) Surges: Stock Moves 6% Higher
Accelerate Diagnostics (AXDX) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
- PR Newswire•5 months ago
Accelerate Diagnostics announces resignation of Joan Martin as Head of Europe, Middle East, and Africa
TUCSON, Ariz. , Sept. 27, 2018 /PRNewswire/ -- Accelerate Diagnostics, Inc. announced today that Joan Martin resigned from his position as Executive Vice President and Head of Europe , Middle East , and ...
